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Available online 15 September 2016AbstractObjective: Our study aimed to evaluate the possible association between hsa-mir-499a (rs3746444 A>G) polymorphism and susceptibility to
breast cancer in an Isfahanian population.
Materials & methods: In this caseecontrol study we enrolled 91 healthy subjects and patients with breast cancer. Allele-specific primer PCR was
applied for genotyping the SNP.
Results: Our study showed that the hsa-mir-499a rs3746444 G allele increased the risk of breast cancer regarding to allele frequency differences
(OR: 1.922; 95% CI: 1.064e3.470; p ¼ 0.02952) and Armitage's trend test (OR: 1.722; p ¼ 0.04732) in comparison with the A allele. In
addition, an in silico attempt to find functional consequences of A>G substation suggested that the G allele may decrease hsa-mir-499a stability
based on calculated free energy differences between A and G alleles.
Conclusion: Our findings illustrated that the mir-499a rs3746444 G polymorphism is associated with higher risk of developing breast cancer in
Isfahanian population.
Copyright © 2016, Shanghai Hengrun Biomedical Technology Research Institute. Publishing services by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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MicroRNAs (miRNAs) are small non-coding single
stranded RNAs (21e25 nucleotides) which negatively regulate
gene expression by binding to imperfect complementary sites
in the 30 untranslated regions (30 UTRs) of their mRNA targets
[1]. Bioinformatics studies point out that a single miRNA can
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under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4in expression of a specific miRNA may have pathological and
physiological outcome [2]. The connection between miRNAs
and cancer was firstly recognized in 2006 [3] among chronic
lymphocytic leukemia patients. MiRNAs has a key role in
cancer biology due to their function in the regulation of cellular
processes, including growth, differentiation and apoptosis [4].
Point mutations in miRNA and mRNA sequences, loss or
mutation in the promoter regions for specific miRNA clusters,
and epigenetic changes may disrupt miRNA activity in cancer
cells [5]. In addition, single nucleotide polymorphisms (SNPs)
at the miRNA gene region (miR-SNPs) may alter miRNA
expression and/or maturation [6e8]. In spite of existence of
various reports for correlation between the SNPs and physio-
logical events [9], few association studies have shown the
miRNA related SNPs in complex disease such as cancer.h Institute. Publishing services by Elsevier B.V. This is an open access article
.0/).
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nosed malignancy worldwide and the most common kind of
cancer among women in developed countries [10]. Recently,
we identified genetic variants in the target site of mRNA and
precursor miRNA sequence as possible biomarkers in BC
[11,12]. In this study, we have investigated the possible as-
sociation between hsa-mir-499a rs3746444 polymorphism
(n.73A>G) and BC risks.
2. Materials and methods2.1. Bioinformatics analysisMiRNASNP V1.0 bioinformatics online tool (http://bioguo.
org/miRNASNP/index.php) [13] was used to predict the effect
of the rs3746444 polymorphism (n.73A>G) within hsa-mir-
499a stem-loop. Predicted free energy hairpin structure of
mir-499a stem-loop with the A and G allele was assumed to
address SNPs impact on the mature miRNA biogenesis
procedure.2.2. Study subjects91 blood samples from women with BC (43 samples) and
healthy controls (48 samples) from August 2013 and August
2014 were collected from the Sayed-ol-Shohada Hospital,
Isfahan, Iran for this study. BC samples were definite after
clinical, mammography, and serological examination. In this
study, control samples with any history of cancer were
excluded. This study protocol was approved by Payame Noor
University, Yazd, Iran, and written informed consents were
acquired from all participants.2.3. SNP genotypingFig. 1. Representative PCR amplicons of allele-specific primer PCR resolved
by 1.5% agarose gel electrophoresis to detect the pre-miRNA-499 rs3746444
A>G polymorphism. Lanes 1 and 2: A/A; lanes 3 and 4: A/A; lanes 5 and 6:
A/G; lanes 7 and 8: A/A; M: DNA marker.DNA was isolated from whole blood samples by using
PrimePrep Genomic DNA Isolation kit (GeNetBio, Chung-
nam, South Korea), according to the manufacturer's protocol,
and the DNA purity was measured by spectrophotometer
(NanoDrop 1000; Thermo Fisher Scientific Inc., Wilmington,
DE, USA). Allele-specific primer polymerase chain reaction
(ASP-PCR) assay was applied to genotype SNP [14]. SNP
genotyping was performed by using A allele specific forward:
50AGCACAGACTTGCTGTGTT30, G allele specific forward:
50AGCACAGACTTGCTGTGTC30, and common reverse:
50GGTGAAAGAGAAGCGTAAGA30 primers. Standard
cycling was performed in a thermocycler (ASTEC PC-818;
ASTEC, Fukuoka, Japan) under the following conditions:
Initial denaturation at 96 C for 2 min followed by 35 cycles of
94 C for 30 s, 52.5 C for 30 s, and 72 C for 30 s, and finally
72 C for 7 min. PCR reactions with A allele specific forward
and G allele specific forward primers were performed sepa-
rately (two reactions are needed for each sample). The allele
specific PCR product was electrophoresed by 1.5% agarose gel
electrophoresis in 1X Tris-Borate-EDTA buffer at 100 V and
stained with RedSafe Nucleic Acid Staining solution (Boca
Scientific, Inc., Boca Raton, FL, USA) for visualization. Theamplicon sizes for hsa-mir-499a rs3746444 polymorphism
(A>G) were 214 bp for both alleles (Fig. 1).2.4. Statistical testsStatistical analysis was assessed by comparing case and
control samples using the DeFinetti program (https://ihg.gsf.
de/cgi-bin/hw/hwa1.pl) to evaluate the association between
the SNP and BC. Odds ratios (ORs) with 95% confidence
intervals (CIs), and the Armitage's trend test were estimated
using Pearson test. In addition, Logistic regression models
were used to determine if odds ratios (OR) are associated with
95% confidence intervals (95% CI). P < 0.05 was considered
as statistically significant criteria. Moreover, statistical power
calculation was performed by OSSE online tool (http://osse.
bii.a-star.edu.sg/index.php).
3. Results3.1. Bioinformatics analysisIn silico predictions suggested that rs3746444 G allele may
decrease hsa-mir-499a stability based on calculated free en-
ergy difference between A and G alleles. Free energy for A
and G allele was 62.32 and 61.92 kcal/mol, respectively.3.2. Statistical testsThe frequency distribution of hsa-miR-499a rs3746444
polymorphism (A>G) alleles in BC patients and healthy sub-
jects are shown in Table 1. A significant differencewas observed
between case and control cohorts. TheG allele increased the risk
of BC regarding to allele frequency difference (OR: 1.922; 95%
CI: 1.064e3.470; p ¼ 0.02952) and Armitage's trend test (OR:
1.722; p¼ 0.04732) in comparisonwith theA allele (Table 1). In
addition, the G allele by dominant model was associated with
BC (A/G þ G/G vs A/A; OR: 2.567; 95% CI: 1.034e6.368;
p ¼ 0.03945).
Table 1
Allelic frequencies and association test of hsa-mir-499a rs3746444 A>G SNP
in cancer-free females and patients with breast cancer.
Alleles Control,
n (%)
Breast
cancer,
n (%)
Allele frequency
difference
Armitage's trend
test
Odds ratio (95%CI) p-value Odds ratio p-value
A 59 (61) 39 (45) 1.00 1.00
G 37 (39) 47 (55) 1.92 (1.064e3.470) 0.029 1.72 0.047
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In recent years, it has been revealed that miRNAs are
critical members of complex regulatory systems. SNPs or
mutations occurring in the miRNA gene region may disturb
the properties of miRNAs and result in defect in protein
translation of target mRNAs [15]. The hsa-mir-499a
rs3746444 polymorphism contains A>G nucleotide substitu-
tion, that results in an alteration from an A:U pair to a G:U
mismatch in the stem-loop structure of the mir-499a precursor
(DDG ¼ 0.4 kcal/mol; G vs A allele). In the current study, it
has been found the hsa-miR-499a rs3746444 G allele and G
allele carriers (individuals with G/G and A/G genotypes) are
associated with the BC incidence in Isfahanian population.
Growing evidence has shown that rs3746444 SNP has
different effects on different kinds of cancers and population.
For instance, Wang et al. reviewed eleven investigations of
Asian and four studies of Caucasian ethnics, and found that the
mir-499a rs3746444 G allele has different effects in various
populations [16]. In summary, Wang et al. utilized meta-
analysis of 7188 cases and 8548 controls and found a signif-
icant correlation between rs3746444 polymorphism and
increased BC risk in the subgroup of Asian population [16].
Similarly, the present investigation and studies performed by
Hu et al. and Omrani et al. suggested that the presence of G
allele significantly increase BC risk [17,18].
Generally, in this case-control study of BC in Isfahan, Iran,
it has been demonstrated that the genetic polymorphism in the
hsa-mir-499a (rs3746444 A>G) gene is associated with
increased risk of BC incidence. One of the limitations of this
study is comparatively small sample size (statistical power:
33%). Large group and diverse ethnicity studies are needed for
more proofs.
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